Nomura Holdings
IMUC

Nomura Holdings’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Nomura Holdings’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-554
Closed -$5K – 1534
2016
Q2 		$5K Buy
+554
New +$5.7K ﹤0.01% 1213
2015
Q2 		– Sell
-2,650
Closed -$60K – 2265
2015
Q1 		$60K Buy
+2,650
New +$66.5K ﹤0.01% 1638
2014
Q4 		– Sell
-13
Closed – – 3126
2014
Q3 		$0 Buy
+13
New +$501 ﹤0.01% 3361
2014
Q1 		– Sell
-993
Closed -$37K – 3121
2013
Q4 		$37K Buy
+993
New +$94.1K ﹤0.01% 1905

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nomura Holdings's IMUC Position: Q3 2016 in Review

Nomura Holdings sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q3 2016, closing a stake of 554 shares — an estimated $5K sold.

Nomura Holdings first reported a position in IMUC in Q4 2013 and held it in 4 quarters. The position peaked at $60K in Q1 2015. 31 funds tracked by Wall St. Rank hold IMUC as of Q3 2016.

  • Nomura Holdings reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q3 2016 after selling out during the quarter.
  • Nomura Holdings sold 554 ImmunoCellular Therapeutics, Ltd. shares in Q3 2016, an estimated $5K.
  • Nomura Holdings first reported a position in ImmunoCellular Therapeutics, Ltd. in Q4 2013 and held it in 4 quarters.
  • Nomura Holdings's ImmunoCellular Therapeutics, Ltd. position peaked at $60K in Q1 2015.
  • 31 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q3 2016.

Based on Nomura Holdings's 13F filing for Q3 2016, filed 14 Nov 2016.